Abstract
Bisphosphonates are indicated for treatment of bone metabolic and neoplastic diseases aiming to control the resorption of this tissue. These drugs show high affinity to mineral tissue and are released after a traumatic or inflammatory stimulus. Once released, bisphosphonates act by inducing apoptosis of osteoclasts and inhibiting the maturation of these cells. The installation of osseoint…